E

Eye Doctors of Arizona | Shea Park

Research site

(Unclaimed)

Location

10255 N. 32nd St STE B, Phoenix, Arizona, United States of America

Site insights

Top conditions

Top treatments

phentolamine

Perfluorohexyloctane

Phentolamine

Tavilermide

PG324

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 7 total trials

A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease

A 4-Week, Randomized, Double-Masked, Parallel-Group, Active-Controlled, Multicenter Study Evaluating Lifitegrast/Perfluorohexyloctane Fixed-Dose Comb...

Enrolling

Dry Eye Disease

Drug: Vehicle

Drug: Lifitegrast/Perfluorohexyloctane Fixed Dose Combination

iStent Inject New Enrollment Post-Approval Study

Study to evaluate the rate of clinically relevant complications associated with iStent inject placement in the post-market setting.

Active, not recruiting

Glaucoma

Glaucoma, Open-Angle

Device: iStent Inject Implantation

OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity (LYNX-3)

The goal of this clinical trial is to learn if Phentolamine Ophthalmic Solution works to treat adults that have had keratorefractive surgery and have...

Enrolling

Vision Loss Night

Vision Disorders

Drug: 0.75% Phentolamine Ophthalmic Solution

Drug: Placebo

Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction

This study is designed to see how safe and effective a new eye drop, called Reformulated PG324, is for lowering eye pressure in people with open-angl...

Active, not recruiting

Open Angle Glaucoma

Ocular Hypertension

Drug: Netarsudil 0.02%/latanoprost 0.005% ophthalmic solution

Drug: Netarsudil 0.01%/latanoprost 0.005% ophthalmic solution